Rohto Pharmaceutical Co Ltd

Common Name

Rohto Pharmaceutical

Country

Japan

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

9,144

Ticker

4527

Exchange

TOKYO STOCK EXCHANGE

Website

www.rohto.co.jp

Description

Rohto Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, specializing in the research, development, and distribution of a diverse range of health and wellness products. Est... Show more

Financial Statements of Rohto Pharmaceutical

Below are the financial statements of Rohto Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of JPY	2024	2023
Current assets	—	—
Cash and deposits	89.21^a	79.95^a
Notes and accounts receivable - trade	44.74^a	39.69^a
Electronically recorded monetary claims - operating	24.78^a	21.33^a
Merchandise and finished goods	26.41^a	22.45^a
Work in process	3.91^a	3.41^a
Raw materials and supplies	16.33^a	15.2^a
Other	9.77^a	8.58^a
Allowance for doubtful accounts	-0.41^a	-0.36^a
Total current assets	214.76^a	190.25^a
Property, plant and equipment	—	—
Buildings and structures	67.7^a	65.12^a
Accumulated depreciation	-37.82^a	-35.49^a
Buildings and structures, net	29.87^a	29.63^a
Machinery, equipment and vehicles	70.23^a	66.2^a
Accumulated depreciation	-57.18^a	-53.79^a
Machinery, equipment and vehicles, net	13.05^a	12.41^a
Tools, furniture and fixtures	20.58^a	19.13^a
Accumulated depreciation	-17.23^a	-16.14^a
Tools, furniture and fixtures, net	3.34^a	2.99^a
Land	15.01^a	15.05^a
Construction in progress	4.29^a	3.54^a
Other	4.61^a	3.62^a
Accumulated depreciation	-1.57^a	-1.04^a
Other, net	3.04^a	2.57^a
Total property, plant and equipment	68.61^a	66.18^a
Intangible assets	—	—
Goodwill	2.29^a	2.56^a
Other	6.93^a	7^a
Total intangible assets	9.22^a	9.56^a
Investments and other assets	—	—
Investment securities	44.34^a	33.64^a
Long-term loans receivable	5.99^a	5.69^a
Deferred tax assets	3.87^a	5.37^a
Other	6.4^a	6.12^a
Allowance for doubtful accounts	-7.01^a	-7.13^a
Total investments and other assets	53.59^a	43.69^a
Assets	—	—
Total non-current assets	131.42^a	119.43^a
Total assets	346.18^a	309.68^a
Current liabilities	—	—
Notes and accounts payable - trade	16.99^a	16.03^a
Electronically recorded obligations - operating	4.13^a	2.69^a
Short-term borrowings	5.3^a	4.18^a
Accrued expenses	21.99^a	20.78^a
Income taxes payable	5.07^a	5.05^a
Accrued consumption taxes	1.57^a	1.18^a
Provision for bonuses	3.69^a	3.54^a
Provision for bonuses for directors (and other officers)	0.05^a	0.05^a
Refund liabilities	15.16^a	15.34^a
Other	13.13^a	11.33^a
Total current liabilities	87.09^a	80.16^a
Non-current liabilities	—	—
Long-term borrowings	5.19^a	7.52^a
Deferred tax liabilities	1.6^a	1.17^a
Retirement benefit liability	2.55^a	3.1^a
Provision for loss on guarantees	0.04^a	0.04^a
Other	2.68^a	2.6^a
Total non-current liabilities	12.05^a	14.44^a
Total liabilities	99.14^a	94.6^a
Shareholders' equity	—	—
Share capital	6.5^a	6.5^a
Capital surplus	4.52^a	5.29^a
Retained earnings	209.4^a	184.01^a
Treasury shares	-4.94^a	-4.94^a
Total shareholders' equity	215.48^a	190.86^a
Accumulated other comprehensive income	—	—
Valuation difference on available-for-sale securities	11.28^a	7.95^a
Foreign currency translation adjustment	18.59^a	10.65^a
Remeasurements of defined benefit plans	0.59^a	-0.28^a
Total accumulated other comprehensive income	30.46^a	18.32^a
Net assets	—	—
Share acquisition rights	0.38^a	0.38^a
Non-controlling interests	0.71^a	5.51^a
Total net assets	247.04^a	215.08^a
Total liabilities and net assets	346.18^a	309.68^a

Download Data

Verified Sources Behind Rohto Pharmaceutical’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Rohto Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Rohto Pharmaceutical's Financial Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Rohto Pharmaceutical Co Ltd

Financial Statements of Rohto Pharmaceutical

Verified Sources Behind Rohto Pharmaceutical’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Kobayashi Pharmaceutical Co Ltd

Lion Corp

Unicharm Corp

NH Foods Ltd

Japan Tobacco Inc

Seven & i Holdings Co Ltd